Basics Aligos Therapeutics, Inc. IPO Date: October 16, 2020 Sector: Healthcare Industry: Biotech Market Cap: $34.73M Activated in VL: True Average Daily Range Avg Daily Range: $0.45 | 4.40% Avg Daily Range (30 D): $0.39 | 7.50% Avg Daily Range (90 D): $0.92 | 6.26% Institutional Daily Volume Avg Daily Volume: .2M Avg Daily Volume (30 D): .15M Avg Daily Volume (90 D): .19M Trade Size Avg Trade Size (Sh.): 150 Avg Trade Size (Sh.) (30 D): 121 Avg Trade Size (Sh.) (90 D): 88 Institutional Trades Total Inst.Trades: 100 Avg Inst. Trade: $2.42M Avg Inst. Trade (30 D): $.92M Avg Inst. Trade (90 D): $.71M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.3M Avg Closing Trade (30 D): $.69M Avg Closing Trade (90 D): $.69M Avg Closing Volume: 13.54K         News May 16, 2025 @ 12:00 PM Aligos Therapeutics Announces Inducement Grants Un... Source: N/A Mar 14, 2025 @ 12:00 PM Aligos Therapeutics Announces Inducement Grants Un... Source: Aligos Therapeutics, Inc. Mar 3, 2025 @ 1:00 PM Aligos Therapeutics to Announce 4th Quarter 2024 F... Source: N/A Dec 13, 2024 @ 1:00 PM Aligos Therapeutics Announces Inducement Grants Un... Source: Aligos Therapeutics, Inc. Oct 11, 2024 @ 12:00 PM Aligos Therapeutics Announces Inducement Grants Un... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-11.02 $5.12 $-13.1 Diluted EPS $-18.25 $-2.11 $-13.1 Revenue $ 3.23M $ .31M $ .61M Gross Profit $ $ $ Net Income / Loss $ -53.26M $ 43.09M $ -82.15M Operating Income / Loss $ -86.35M $ -19.24M $ -20.56M Cost of Revenue $ $ $ Net Cash Flow $ 49.51M $ 36.77M $ 1.67M PE Ratio     Splits Aug 19, 2024:   25:1